Concepedia

Publication | Open Access

Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity

DOIFull Paper Access

174

Citations

43

References

2019

Year

Philip N. Newsome, Sven Francque, Stephen A. Harrison, Vlad Ratziu, Luc Van Gaal, Salvatore Calanna, Morten Hansen, Martin Linder, Arun J. Sanyal
Alimentary Pharmacology & Therapeutics

Abstract

Semaglutide significantly reduced ALT and hsCRP in clinical trials in subjects with obesity and/or type 2 diabetes.

References

YearCitations

Page 1